Formerly known as Ecochem Research Inc, now doing business as Receptors LLC in same location. Receptors LLC is pioneering the development and commercialization of Artificial Receptor products for proteomics research, pharmaceutical development, bioterrorism/emerging diseases defense, as well as veterinary and clinical diagnostics. Receptors' CARA⢠(Combinatorial Artificial Receptor Array) technology is focused on the development of products which meet the diverse opportunities of proteomics. CARA⢠targets the key issues of proteome separation, protein-protein interaction screening, protein surface topology characterization, and high-throughput inhibitor identification. The creation of stable articial receptors (artificial antibodies) which will bind selected targets with high specificity and sensitivity is critical to the development of both high-throughput and multiplexed proteomics solutions. The DISCOVERY 100 Receptor Array is the platform tool for identification of both targeted artificial receptors and array-derived protein or proteomic fingerprin
